MODERN APPROACHES TO DIAGNOSTICS AND THERAPY OF VAGINAL INFECTIONS
Main Article Content
Abstract
In modern obstetrical and gynecological practice, the problem of disturbing the vaginal microflora is one of the most urgent because of the possibility of developing a whole complex of complications affecting the reproductive function of women. Mixed variants of vaginal infections have been little studied, nevertheless, they must be distinguished, since different forms of coexistence of pathogens require an individual therapeutic approach.
Objective – evaluation of the effectiveness of the use of a new combination gel form preparation for vaginal infections in pregnant women.
Methods of research. The study included 200 pregnant women with vaginal infections: 100 women made up the basic group, received treatment with a new gel preparation Metrogyl Plus within 5 days. The comparison group consisted of 100 patients treated with Clion-D 100. The second stage involved lactobacilli providing colonization resistance of the vaginal biotope.
Results. Efficacy after the end of treatment after 1 month was 99 % in the main group, 94 % in the comparison group (p = 0,12), relapses after treatment at 3 months were revealed in 2 % and 10 % of the observations, respectively, in the study groups (p = 0,02). Placental disorders, the threat of spontaneous abortion, polyhydramnios, gestational pyelonephritis, edema caused by pregnancy, and preeclampsia were collectively observed in the main group less frequently than in the comparison group (p = 0,025). Complications of childbirth and the postpartum period are also noted less frequently in the main group than in the comparison group, which is associated with a much smaller number of relapses after treatment (p = 0,004).
Conclusion. Treatment of vaginal infections with a new gel form preparation in pregnant women is highly effective and is 99 %. The number of relapses after treatment with the combined preparation in the form of a gel is only 2 % after 3 months. Consequently, the use of an effective combination drug in the treatment of vaginal infections, reduces the incidence of complications of pregnancy, childbirth and the postpartum period.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Nikonov AP, Astsaturova OR, Chilova RA, Ishchenko AI, Rafal'skii VV. Infections in obstetrics and gynecology: diagnosis and antimicrobial chemotherapy. A manual for doctors. M.: PAgRI, 2006. 28 р. Russian (Никонов А.П., Асцатурова О.Р., Чилова Р.А., Ищенко А.И., Рафальский В.В. Инфекции в акушерстве и гинекологии: диагностика и антимикробная химиотерапия. Пособие для врачей. М.: ПАгРИ, 2006. 28 с.)
Berek Dzh, Adashi I, Khillard P. red. Gynecology by Emil Novak. Translation from English. M.: Praktika, 2002. 892 р. Russian (Берек Дж., Адаши И., Хиллард П. ред. Гинекология по Эмилю Новаку. Пер с англ. М.: Практика, 2002. 892 с.)
Rumyantseva TA, Sursyakov SA, Khayrullina GA, Chernyshova LA, Gushchin AE. Vaginal discharge in gynecological patients: etiology and approaches to diagnosis. Obstetrics and Gynecology. 2015; (8): 96-101. Russian (Румянцева Т.А., Сурсяков С.А., Хайруллина Г.А., Чернышова Л.А., Гущин А.Е. Вагинальные выделения у пациенток гинекологического профиля: этиология и подходы к диагностике //Акушерство и гинекология. 2015. № 8. С. 96-101)
Sherrard J, Donders GG, White D, Jensen JS. European (IUSTI/WHO) guidline on the management of vaginal discharge. Int. J. STD AIDS. 2011; (8): 421-429. doi: 10.1258/ijsa.2011.011012
Shireva YuV, Sandakova EA, Karpunina TI. Nonspecific aerobic vaginitis – a «new» or «old» disease? (review). Ginekologiya. 2010; 4(13): 154-168. Russian (Ширева Ю.В., Сандакова Е.А., Карпунина Т.И. Неспецифический аэробный вагинит – «новое» или «старое» заболевание? (обзор) //Гинекология. 2010. №4 (13). С. 154-168)
Sobel JD, Subramanian C, Foxman B, Fairfax M, Gygax SE. Mixed Vaginitis – More than coinfection and with therapeutic implications. Curr. Infect. Dis. Rep. 2013; 15(2): 104-108. doi: 10.1007/s11908-013-0325-5
Bebneva TN, Dobretsova TA. Mixed vaginal infections: a new ideology. Ed. VE Radzinskogo i AM Savichevoy. 2016. 24 р. Russian (Бебнева Т.Н., Добрецова Т.А. Смешанные вагинальные инфекции: новая идеология. Под ред. В.Е. Радзинского и А.М. Савичевой. 2016. 24 с.)
Kravchenko EN. Immunocorrective therapy in the complex treatment of nonspecific bacterial vaginitis. Obstetrics and Gynecology: news, views, education. 2015; (1): 49-54. Russian (Кравченко Е.Н. Иммунокоррегирующая терапия в комплексном лечении неспецифического бактериального вагинита //Акушерство и гинекология: новости, мнения, обучение. 2015. № 1. С. 49-54)
Sobel JD, Reichman O, Misra D, Yoo W. Prognosis and Treatment of Desquamative Inflammatory Vaginitis. Obstet. Gynecol. 2011; 117(4): 850-855. doi: 10.1097/AOG.0b013e3182117c9e
Radzinskiy VE, Ordiyants IM. Two-stage therapy of vaginal infections. M.: Redaktsiya zhurnala Status Praesens. 2012. 16 р. Russian (Радзинский В.Е., Ордиянц И.М. Двухэтапная терапия вагинальных инфекций. М.: Редакция журнала Status Praesens, 2012. 16 с.)
Radzinskiy VE, Ordiyants IM. Investigation of BIOS: a comparative evaluation of various treatment regimens for bacterial vaginosis and nonspecific vulvovaginitis. Status Praesens. 2013; 1(12): 52-55. Russian (Радзинский В.Е., Ордиянц И.М. Исследование БИОС: сравнительная оценка различных схем лечения бактериального вагиноза и неспецифического вульвовагинита //Status Praesens. 2013. № 1(12). С. 52-55)
Sexually Transmitted Diseases Treatment Guidelines, 2015: Recommendations and Reports. CDC, 2015. 138 р.
Schwebke JR, Desmond R. A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am. J. Obstet. Gynecol. 2007; 196(6): 517.e1-6
Management of Vaginal Discharge in Non-Genitourinary Medicine Settings: Clinical Effectiveness Unit February 2012. – URL: http://www.fsrh.org/pdfs/CEUGuidanceVaginalDischarge.pdf
Federal clinical guidelines for managing patients with bacterial vaginosis. M.: Minzdrav Rossii, 2013. 16 р. Russian (Федеральные клинические рекомендации по ведению больных бактериальным вагинозом. М.: Минздрав России, 2013. 16 с.)
Donders GG, Zodzika J, Rezeberga D. Treatment of bacterial vaginosis: what we have and what we miss. Expert. Opin. Pharmacother. 2014; 15(5): 645-657. doi: 10.1517/14656566.2014.881800. Epub 2014 Feb 28